Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cirrhosis Portal”

817 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 817 results

Not applicableUnknownNCT03173287
What this trial is testing

Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI

Who this might be right for
Liver FibrosisMRIIVIM+1 more
University Hospital, Clermont-Ferrand 63
Not applicableStudy completedNCT06384443
What this trial is testing

Proton Pump Inhibitors in Cirrhotic Patients

Who this might be right for
Proton Pump Inhibitor Adverse ReactionLiver Cirrhosis
National Liver Institute, Egypt 1,000
Not applicableStudy completedNCT04332484
What this trial is testing

Global Coagulation Assessment in Cirrhosis and ACLF

Who this might be right for
Acute-On-Chronic Liver FailureCirrhosis, Liver
Post Graduate Institute of Medical Education and Research, Chandigarh 142
Not applicableStudy completedNCT04267406
What this trial is testing

ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal Hypertension

Who this might be right for
Coagulation DisorderCirrhosis, Liver
Ataturk University 64
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT02143778
What this trial is testing

Assessing Portal Hypertension With Methacetin Breath Test

Who this might be right for
Patients With Compensated Liver Cirrhosis
Meridian Bioscience, Inc. 246
Testing effectiveness (Phase 2)Study completedNCT01188733
What this trial is testing

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionEsophageal Varices
Mayo Clinic 39
Not applicableStudy completedNCT07811713
What this trial is testing

Effect of LSD on Renal Function in Cirrhotic Patients With Portal Hypertension

Who this might be right for
Cirrhosis, LiverSplenectomy; StatusRenal Function Abnormal+1 more
Northern Jiangsu People's Hospital 496
Not applicableStudy completedNCT04994548
What this trial is testing

Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension

Who this might be right for
Esophageal NeoplasmsCirrhosisPortal Hypertension
Central Hospital, Nancy, France 112
Testing effectiveness (Phase 2)UnknownNCT01724697
What this trial is testing

Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis

Who this might be right for
Liver CirrhosisEnd Stage Liver Disease
Air Force Military Medical University, China 240
Testing effectiveness (Phase 2)Study completedNCT03712280
What this trial is testing

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

Who this might be right for
Hepatic CirrhosisHepatic Encephalopathy (HE)
Mallinckrodt 50
Post-approval studies (Phase 4)UnknownNCT05920213
What this trial is testing

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy Stage 2Hepatic Encephalopathy Stage 3Hepatic Encephalopathy Stage 4
Jinnah Postgraduate Medical Centre 360
Large-scale testing (Phase 3)Study completedNCT02016196
What this trial is testing

Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS

Who this might be right for
Cirrhosis
University Hospital, Toulouse 211
Not applicableLooking for participantsNCT07461532
What this trial is testing

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

Who this might be right for
CirrhosisSplenectomyPortal Vein Thrombosis+1 more
Northern Jiangsu People's Hospital 20
Not applicableUnknownNCT05036031
What this trial is testing

Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study

Who this might be right for
Acute-On-Chronic Liver FailureLiver CirrhosisLiver Transplant; Complications
RenJi Hospital 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07412236
What this trial is testing

A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.

Who this might be right for
Liver FibrosisLiver Fibrosis in Chronic Hepatitis B
Beijing Continent Pharmaceutical Co, Ltd. 1,208
Post-approval studies (Phase 4)Study completedNCT02344719
What this trial is testing

Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis

Who this might be right for
CirrhosisPortal Hypertension
Medical University of Vienna 30
Testing effectiveness (Phase 2)UnknownNCT01741090
What this trial is testing

The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis

Who this might be right for
Alcoholic Liver Cirrhosis
Yonsei University 12
Large-scale testing (Phase 3)UnknownNCT02975323
What this trial is testing

Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension

Who this might be right for
Portal Hypertension
Aga Khan University 50
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Next Page